CAMBRIDGE, Mass.--(BUSINESS WIRE)--Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), a leading RNAi therapeutics company, today announced that management will present a company overview at the Morgan Stanley Global Healthcare Unplugged Conference on Tuesday, September 9, 2008, at 3:55 p.m. ET at the Grand Hyatt New York in New York City.
